SoftBank swings to $7 billion net loss in second quarter as tech selloff weighs on results
SoftBank Group announces fiscal second-quarter results for the year ending March 31, 2027.
SoftBank swings to $7 billion net loss in second quarter as tech selloff weighs on results
SoftBank Group announces fiscal second-quarter results for the year ending March 31, 2027.
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
1 report1 sourceSimilarity 0.39
SoftBank posts unexpected $7bn loss on data centre writedown
AI-focused Japanese group blames first quarterly loss in nearly two years on ‘evolving requirements’ in US projects
Financial Times
1 report1 sourceSimilarity 0.27
Tokenization platform Securitize gains 10% postmarket on Q3 results, move into asset-backed finance
Securitize saw growth in tokenization last quarter and announced its expansion into asset-backed finance through the acquisition of River One.
CNBC
1 report1 sourceSimilarity 0.24
Skydance outlines its $6 billion in planned cost savings. Here's the breakdown
The updates came alongside a third-quarter earnings report for the legacy Paramount Skydance.
CNBC
3 reports3 sourcesSimilarity 0.23
Trump questions midterm election results, revives voting-machine conspiracy
President Trump's questioning of the legitimacy of his loss in the 2020 election culminated with an attack on the U.S. Capitol by a mob of his supporters. Grouped from 3 articles across 3 sources.
ABC News, BBC News, CNBC
1 report1 sourceSimilarity 0.23
South Africa’s ANC suffers worst-ever local elections result
South Africa's ANC has suffered its worst-ever local elections result, securing just 30% of the vote.
Al Jazeera
3 reports3 sourcesSimilarity 0.23
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound
The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes. Grouped from 3 articles across 3 sources.
ABC Australia, CNBC, Euronews